According to the expression differences of DDIT4, SULF1, TPTEP1, miR-181d-5p, and miR-148b-3p in CRC tissues compared to the adjacent normal tissues, we believe our results provide a valuable resource in order to find biomarkers clinicopathologically relevant to CRC patients. This evidence concerns the gene SULF1 and colorectal carcinoma.